Global Tumor Ablation Market Growth 2019-2024

Published On: July 2019 | Report ID: 180292 | Category: Pharmaceuticals and HealthcarePages: 139

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.

The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.

The classification of Tumor Ablation includes Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation and others. The proportion of Radiofrequency (RF) Ablation in 2015 is about 50.6%, and the proportion of Microwave Ablation in 2015 is about 21.7%.

Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2015 is about 28.5%.

According to this study, over the next five years the Tumor Ablation market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Tumor Ablation business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Ablation market by product type, application, key manufacturers and key regions and countries.

This study considers the Tumor Ablation value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Radiofrequency (RF) Ablation

Microwave Ablation

Cryoablation

Other Technologies

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Liver Cancer

Lung Cancer

Kidney Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Angiodynamics

Medtronic

Boston Scientific

Galil Medical

Neuwave Medical

Misonix

Merit Medical

Sonacare Medical

EDAP TMS

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Tumor Ablation consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Tumor Ablation market by identifying its various subsegments.

Focuses on the key global Tumor Ablation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Tumor Ablation with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Tumor Ablation submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Tumor Ablation Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tumor Ablation Consumption 2014-2024

2.1.2 Tumor Ablation Consumption CAGR by Region

2.2 Tumor Ablation Segment by Type

2.2.1 Radiofrequency (RF) Ablation

2.2.2 Microwave Ablation

2.2.3 Cryoablation

2.2.4 Other Technologies

2.3 Tumor Ablation Consumption by Type

2.3.1 Global Tumor Ablation Consumption Market Share by Type (2014-2019)

2.3.2 Global Tumor Ablation Revenue and Market Share by Type (2014-2019)

2.3.3 Global Tumor Ablation Sale Price by Type (2014-2019)

2.4 Tumor Ablation Segment by Application

2.4.1 Liver Cancer

2.4.2 Lung Cancer

2.4.3 Kidney Cancer

2.4.4 Others

2.5 Tumor Ablation Consumption by Application

2.5.1 Global Tumor Ablation Consumption Market Share by Application (2014-2019)

2.5.2 Global Tumor Ablation Value and Market Share by Application (2014-2019)

2.5.3 Global Tumor Ablation Sale Price by Application (2014-2019)

3 Global Tumor Ablation by Players

3.1 Global Tumor Ablation Sales Market Share by Players

3.1.1 Global Tumor Ablation Sales by Players (2017-2019)

3.1.2 Global Tumor Ablation Sales Market Share by Players (2017-2019)

3.2 Global Tumor Ablation Revenue Market Share by Players

3.2.1 Global Tumor Ablation Revenue by Players (2017-2019)

3.2.2 Global Tumor Ablation Revenue Market Share by Players (2017-2019)

3.3 Global Tumor Ablation Sale Price by Players

3.4 Global Tumor Ablation Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Tumor Ablation Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Tumor Ablation Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Tumor Ablation by Regions

4.1 Tumor Ablation by Regions

4.1.1 Global Tumor Ablation Consumption by Regions

4.1.2 Global Tumor Ablation Value by Regions

4.2 Americas Tumor Ablation Consumption Growth

4.3 APAC Tumor Ablation Consumption Growth

4.4 Europe Tumor Ablation Consumption Growth

4.5 Middle East & Africa Tumor Ablation Consumption Growth

5 Americas

5.1 Americas Tumor Ablation Consumption by Countries

5.1.1 Americas Tumor Ablation Consumption by Countries (2014-2019)

5.1.2 Americas Tumor Ablation Value by Countries (2014-2019)

5.2 Americas Tumor Ablation Consumption by Type

5.3 Americas Tumor Ablation Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Tumor Ablation Consumption by Countries

6.1.1 APAC Tumor Ablation Consumption by Countries (2014-2019)

6.1.2 APAC Tumor Ablation Value by Countries (2014-2019)

6.2 APAC Tumor Ablation Consumption by Type

6.3 APAC Tumor Ablation Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Tumor Ablation by Countries

7.1.1 Europe Tumor Ablation Consumption by Countries (2014-2019)

7.1.2 Europe Tumor Ablation Value by Countries (2014-2019)

7.2 Europe Tumor Ablation Consumption by Type

7.3 Europe Tumor Ablation Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Tumor Ablation by Countries

8.1.1 Middle East & Africa Tumor Ablation Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Tumor Ablation Value by Countries (2014-2019)

8.2 Middle East & Africa Tumor Ablation Consumption by Type

8.3 Middle East & Africa Tumor Ablation Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Tumor Ablation Distributors

10.3 Tumor Ablation Customer

11 Global Tumor Ablation Market Forecast

11.1 Global Tumor Ablation Consumption Forecast (2019-2024)

11.2 Global Tumor Ablation Forecast by Regions

11.2.1 Global Tumor Ablation Forecast by Regions (2019-2024)

11.2.2 Global Tumor Ablation Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Tumor Ablation Forecast by Type

11.8 Global Tumor Ablation Forecast by Application

12 Key Players Analysis

12.1 Angiodynamics

12.1.1 Company Details

12.1.2 Tumor Ablation Product Offered

12.1.3 Angiodynamics Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Angiodynamics News

12.2 Medtronic

12.2.1 Company Details

12.2.2 Tumor Ablation Product Offered

12.2.3 Medtronic Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Medtronic News

12.3 Boston Scientific

12.3.1 Company Details

12.3.2 Tumor Ablation Product Offered

12.3.3 Boston Scientific Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Boston Scientific News

12.4 Galil Medical

12.4.1 Company Details

12.4.2 Tumor Ablation Product Offered

12.4.3 Galil Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Galil Medical News

12.5 Neuwave Medical

12.5.1 Company Details

12.5.2 Tumor Ablation Product Offered

12.5.3 Neuwave Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Neuwave Medical News

12.6 Misonix

12.6.1 Company Details

12.6.2 Tumor Ablation Product Offered

12.6.3 Misonix Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Misonix News

12.7 Merit Medical

12.7.1 Company Details

12.7.2 Tumor Ablation Product Offered

12.7.3 Merit Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Merit Medical News

12.8 Sonacare Medical

12.8.1 Company Details

12.8.2 Tumor Ablation Product Offered

12.8.3 Sonacare Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Sonacare Medical News

12.9 EDAP TMS

12.9.1 Company Details

12.9.2 Tumor Ablation Product Offered

12.9.3 EDAP TMS Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 EDAP TMS News

13 Research Findings and Conclusion

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.